A user initiated a six-month self-experiment using a combination of ModGRF 1-29 (CJC-1295 no DAC) and GHRP-2. He chose to dose the peptides separately twice daily—once upon waking and once before bed—specifically to monitor long-term efficacy without making frequent adjustments to the protocol.